RESUMEN
Polymeric supramolecular hydrogels (PSHs) leverage the thermodynamic and kinetic properties of non-covalent interactions between polymer chains to govern their structural characteristics. As these materials are formed via endothermic or exothermic equilibria, their thermal response is challenging to control without drastically changing the nature of the chemistry used to join them. In this study, we introduce a novel class of PSHs utilizing the intercalation of double-stranded DNA (dsDNA) as the primary dynamic non-covalent interaction. The resulting dsDNA intercalating supramolecular hydrogels (DISHs) can be tuned to exhibit both endothermically or exothermically driven binding through strategic selection of intercalators. Bifunctional polyethylene glycol (MW ~ 2000 Da) capped with intercalators of varying hydrophobicity, charge, and size (acridine, psoralen, thiazole orange, and phenanthridine) produced DISHs with comparable moduli (500 - 1000 Pa) but unique thermal viscoelastic response. Notably, acridine-based cross-linkers displayed invariant and even increasing elasticity with temperature, suggesting an endothermic binding mechanism. This methodology expands the set of structure-properties available to biomass-derived DNA biomaterials and promises a new material system where a broad set of thermal and viscoelastic responses can be obtained due to the sheer number and variety of intercalating molecules.
RESUMEN
Tailed double-stranded DNA bacteriophage employs a protein terminase motor to package their genome into a preformed protein shell-a system shared with eukaryotic dsDNA viruses such as herpesviruses. DNA packaging motor proteins represent excellent targets for antiviral therapy, with Letermovir, which binds Cytomegalovirus terminase, already licensed as an effective prophylaxis. In the realm of bacterial viruses, these DNA packaging motors comprise three protein constituents: the portal protein, small terminase and large terminase. The portal protein guards the passage of DNA into the preformed protein shell and acts as a protein interaction hub throughout viral assembly. Small terminase recognises the viral DNA and recruits large terminase, which in turn pumps DNA in an ATP-dependent manner. Large terminase also cleaves DNA at the termination of packaging. Multiple high-resolution structures of each component have been resolved for different phages, but it is only more recently that the field has moved towards cryo-EM reconstructions of protein complexes. In conjunction with highly informative single-particle studies of packaging kinetics, these structures have begun to inspire models for the packaging process and its place among other DNA machines.
Asunto(s)
ADN Viral , Proteínas Virales , ADN Viral/genética , ADN Viral/metabolismo , Proteínas Virales/metabolismo , Proteínas Virales/genética , Endodesoxirribonucleasas/metabolismo , Endodesoxirribonucleasas/genética , Empaquetamiento del Genoma Viral/fisiología , Empaquetamiento del ADN , Bacteriófagos/genética , Bacteriófagos/fisiología , Bacteriófagos/metabolismo , Genoma ViralRESUMEN
Fibroblast activation protein (FAP) has attracted considerable attention as a possible target for the radiotherapy of solid tumors. Unfortunately, initial efforts to treat solid tumors with FAP-targeted radionuclides have yielded only modest clinical responses, suggesting that further improvements in the molecular design of FAP-targeted radiopharmaceutical therapies (RPT) are warranted. In this study, we report several advances on the previously described FAP6 radioligand that increase tumor retention and accelerate healthy tissue clearance. Seven FAP6 derivatives with different linkers or albumin binders were synthesized, radiolabeled, and investigated for their effects on binding and cellular uptake. The radioligands were then characterized in 4T1 tumor-bearing Balb/c mice using both single-photon emission computed tomography (SPECT) and ex vivo biodistribution analyses to identify the conjugate with the best tumor retention and tumor-to-healthy organ ratios. The results reveal an optimized FAP6 radioligand that exhibits efficacy and safety properties that potentially justify its translation into the clinic.
Asunto(s)
Endopeptidasas , Gelatinasas , Proteínas de la Membrana , Ratones Endogámicos BALB C , Radiofármacos , Serina Endopeptidasas , Tomografía Computarizada de Emisión de Fotón Único , Animales , Endopeptidasas/metabolismo , Ratones , Distribución Tisular , Proteínas de la Membrana/metabolismo , Radiofármacos/química , Radiofármacos/síntesis química , Radiofármacos/farmacocinética , Radiofármacos/farmacología , Radiofármacos/uso terapéutico , Gelatinasas/metabolismo , Femenino , Serina Endopeptidasas/metabolismo , Línea Celular Tumoral , Humanos , LigandosRESUMEN
Microbial α-L-fucosidases catalyse the hydrolysis of terminal α-L-fucosidic linkages and can perform transglycosylation reactions. Based on sequence identity, α-L-fucosidases are classified in glycoside hydrolases (GHs) families of the carbohydrate-active enzyme database. Here we explored the sequence-function space of GH29 fucosidases. Based on sequence similarity network (SSN) analyses, 15 GH29 α-L-fucosidases were selected for functional characterisation. HPAEC-PAD and LC-FD-MS/MS analyses revealed substrate and linkage specificities for α1,2, α1,3, α1,4 and α1,6 linked fucosylated oligosaccharides and glycoconjugates, consistent with their SSN clustering. The structural basis for the substrate specificity of GH29 fucosidase from Bifidobacterium asteroides towards α1,6 linkages and FA2G2 N-glycan was determined by X-ray crystallography and STD NMR. The capacity of GH29 fucosidases to carry out transfucosylation reactions with GlcNAc and 3FN as acceptors was evaluated by TLC combined with ESI-MS and NMR. These experimental data supported the use of SSN to further explore the GH29 sequence-function space through machine-learning models. Our lightweight protein language models could accurately allocate test sequences in their respective SSN clusters and assign 34,258 non-redundant GH29 sequences into SSN clusters. It is expected that the combination of these computational approaches will be used in the future for the identification of novel GHs with desired specificities.
RESUMEN
Due to their constrained conformations, cyclic ß2,3-amino acids (cßAA) are key building blocks that can fold peptides into compact and rigid structures, improving peptidase resistance and binding affinity to target proteins, due to their constrained conformations. Although the translation efficiency of cßAAs is generally low, our engineered tRNA, referred to as tRNAPro1E2, enabled efficient incorporation of cßAAs into peptide libraries using the flexible in vitro translation (FIT) system. Here we report on the design and application of a macrocyclic peptide library incorporating 3 kinds of cßAAs: (1R,2S)-2-aminocyclopentane carboxylic acid (ß1), (1S,2S)-2-aminocyclohexane carboxylic acid (ß2), and (1R,2R)-2-aminocyclopentane carboxylic acid. This library was applied to an in vitro selection against the SARS-CoV-2 main protease (Mpro). The resultant peptides, BM3 and BM7, bearing one ß2 and two ß1, exhibited potent inhibitory activities with IC50 values of 40 and 20â nM, respectively. BM3 and BM7 also showed remarkable serum stability with half-lives of 48 and >168â h, respectively. Notably, BM3A and BM7A, wherein the cßAAs were substituted with alanine, lost their inhibitory activities against Mpro and displayed substantially shorter serum half-lives. This observation underscores the significant contribution of cßAA to the activity and stability of peptides. Overall, our results highlight the potential of cßAA in generating potent and highly stable macrocyclic peptides with drug-like properties.
RESUMEN
Because of upregulated expression on cancer-associated fibroblasts, fibroblast activation protein (FAP) has emerged as an attractive biomarker for the imaging and therapy of solid tumors. Although many FAP ligands have already been developed for radiopharmaceutical therapies (RPTs), most suffer from inadequate tumor uptake, insufficient tumor residence times, or off-target accumulation in healthy tissues, suggesting a need for further improvements. Methods: A new FAP-targeted RPT with a novel ligand (FAP8-PEG3-IP-DOTA) was designed by combining the desirable features of several previous ligand-targeted RPTs. Uptake and retention of [111In]In or [177Lu]Lu-FAP8-PEG3-IP-DOTA were assessed in KB, HT29, MDA-MB-231, and 4T1 murine tumor models by radioimaging or ex vivo biodistribution analyses. Radiotherapeutic potencies and gross toxicities were also investigated by monitoring tumor growth, body weight, and tissue damage in tumor-bearing mice. Results: FAP8-PEG3-IP-DOTA exhibited high affinity (half-maximal inhibitory concentration, 1.6 nM) and good selectivity for FAP relative to its closest homologs, prolyl oligopeptidase (half-maximal inhibitory concentration, â¼14.0 nM) and dipeptidyl peptidase-IV (half-maximal inhibitory concentration, â¼860 nM). SPECT/CT scans exhibited high retention in 2 different solid tumor models and minimal uptake in healthy tissues. Quantitative biodistribution analyses revealed tumor-to-healthy-tissue ratios of more than 5 times for all major organs, and live animal studies demonstrated 65%-93% suppression of tumor growth in all 4 models tested, with minimal or no evidence of systemic toxicity. Conclusion: We conclude that [177Lu]Lu-FAP8-PEG3-IP-DOTA constitutes a promising and safe RPT candidate for FAPα-targeted radionuclide therapy of solid tumors.
Asunto(s)
Endopeptidasas , Gelatinasas , Proteínas de la Membrana , Radiofármacos , Serina Endopeptidasas , Animales , Ratones , Radiofármacos/uso terapéutico , Radiofármacos/farmacocinética , Gelatinasas/metabolismo , Humanos , Línea Celular Tumoral , Serina Endopeptidasas/metabolismo , Proteínas de la Membrana/metabolismo , Distribución Tisular , Femenino , Diseño de Fármacos , Lutecio/uso terapéutico , Neoplasias/radioterapia , Neoplasias/diagnóstico por imagen , Neoplasias/metabolismo , Compuestos Heterocíclicos con 1 Anillo/química , Compuestos Heterocíclicos con 1 Anillo/uso terapéutico , Terapia Molecular Dirigida , RadioisótoposRESUMEN
PURPOSE: To compare the accuracy of two digital workflows for producing resin patterns to be cast into metal frameworks compared to an identical framework manufactured conventionally from a wax pattern. MATERIALS AND METHODS: Nine casts were duplicated from a maxillary master cast of a partially edentulous arch. Their accuracy was determined by measuring the same points in two and three dimensions using a reflex microscope, which was also used to measure all frameworks to an accuracy of 4 µm. The same design was used throughout. Three casts were used to make a framework conventionally from an invested wax pattern. Six casts were scanned, and a digital pattern created. Three patterns were milled from a resin block, and three were 3D printed with resin. Then each pattern was cast. RESULTS: The sample size precluded direct statistical conclusions, but no significant differences were found. Duplicate models showed minimal differences compared to the master cast. All patterns and all frameworks showed some level of difference compared to the master cast, but no differences were greater than those reported in the literature as being clinically acceptable. The maximum overall discrepancy between the cast frameworks was 0.64 mm, and at the rest seats was 0.262 mm. CONCLUSION: Within the limitations of this study, given the very small actual differences both within and between the groups of the three different workflows, the use of digitally produced resin patterns prior to their being cast as metal frameworks is both feasible and well within the accepted limits for clinical acceptability.